Association between clinical outcome and gene mutation in children with Fanconi anemia
CHANG Li-Xian, REN Ruan-Ruan, YANG Wen-Yu, ZHANG Jia-Yuan, WAN Yang, LIU Tian-Feng, ZHANG Li, CHEN Xiao-Juan, ZHU Shuai, RUAN Min, CHEN Xia, LIU Xiao-Ming, QI Ben-Quan, ZHANG Ran-Ran, ZOU Yao, CHEN Yu-Mei, ZHU Xiao-Fan
State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
Abstract Objective To investigate the association between clinical outcome and gene mutations in children with Fanconi anemia (FA). Methods A retrospective analysis was performed for the clinical data of six children with the same severity of FA and receiving the same treatment. At first, single cell gel electrophoresis and chromosome breakage induced by mitomycin C were performed for diagnosis. Then the gene detection kit for congenital bone marrow failure diseases or complementation test was used for genotyping of FA. Finally the association between the clinical outcome at 3, 6, 9, or 12 months after treatment and gene mutation was analyzed. Results Of all the six FA children, five had FANCA type disease, and one had FANCM type disease; four children carried two or more FA gene mutations. Among the children with the same severity of FA, those with more FA mutations had a younger age of onset and poorer response to medication, and tended to progress to a severe type. Conclusions Children carrying more than two FA mutations have a poor clinical outcome, and hematopoietic stem cell transplantation should be performed as soon as possible.
CHANG Li-Xian,REN Ruan-Ruan,YANG Wen-Yu et al. Association between clinical outcome and gene mutation in children with Fanconi anemia[J]. CJCP, 2016, 18(8): 742-745.
CHANG Li-Xian,REN Ruan-Ruan,YANG Wen-Yu et al. Association between clinical outcome and gene mutation in children with Fanconi anemia[J]. CJCP, 2016, 18(8): 742-745.
Blanche P.Diagnostic Evaluation of FA[M]//Mary EE,Dave F,Lynn F,et al.Fanconi anemia:Guidelines for diagnosis and management[M].3rd ed.Eugene:Fanconi Anemia Research Fund Inc,2008:34-53.
International Atomic Energy Agency.Dicentric analysis[M]/Cytogenetic analysis for radiation dose assessment:a manual.Vienna:International Atomic Energy Agency,2001:27-59.
[6]
Wang AT,Smogorzewska A.SnapShot:Fanconi anemia and associated proteins[J].Cell,2015,160(1-2):354-354.
[7]
Alan D,D'Andrea MD.The Fanconi anemia and breast cancer susceptibility pathway[J].N Engl J Med,2010,362(20):1901-1919.
[8]
Kutler DI,Singh B,Satagopan J,et al.A 20-year perspective on the international Fanconi anemia Registry (IFAR)[J].Blood 2003,101(4):1249-1256.
[9]
Myers K,Davies SM,Harris RE,et al.The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations[J].Pediatr Blood Cancer,2012,58(3):462-465.
[10]
Seal S,Thompson D,Renwick A,et al.Breast Cancer Susceptibility Collaboration (UK):Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles[J].Nat Genet,2006,38(11):1239-1241.
[11]
Rahman N,Seal S,Thompson D,et al.Breast Cancer Susceptibility Collaboration (UK):PALB2,which encodes a BRCA2-interacting protein,is a breast cancer susceptibility gene[J].Nat Genet 2007,39(2):165-167.
[12]
Reid S,Schindler D,Hanenberg H,et al.Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer[J].Nat Genet,2007,39(2):162-164.
[13]
Wark L,Novak D,Sabbaghian N,et al.Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines[J].Genes Chromosomes Cancer,2013,52(5):480-494.
[14]
Thompson ER,Doyle MA,Ryland GL,et al.Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles[J].PLoS Genet,2012,8(9):el002894.
[15]
Levy-Lahad E,Friedman E.Cancer risks among BRCA1 and BRCA2 mutation carriers[J].Br J Cancer,2007,96(1):11-15.
[16]
Smetsers S,Muter J,Bristow C,et al.Heterozygote FANCD2 mutations associated with childhood T cell ALL and testicular seminoma[J].Fam Cancer,2012,11(4):661-665.
[17]
Koptyra M,Stoklosa T,Hoser G,et al.Monoubiquitinated Fanconi anemia D2(FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis[J].Leukemia,2011,25(8):1259-1267.
[18]
Chang L,Yuan W,Zeng H,et al.Whole exome sequencing reveals concomitant mutations of multiple FA genes in individual Fanconi anemia patients[J].BMC Med Genomics,2014,7:24.
